Cargando…
Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake
BACKGROUND: Coffee consumption is a known inducer of cytochrome P450 1A2 (CYP1A2) enzyme activity. We recently observed that a group of type-2 diabetes patients consumed more caffeine (coffee) on a daily basis than non-type-2 diabetes controls. Here, we investigated whether type-2 diabetes cases may...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052791/ https://www.ncbi.nlm.nih.gov/pubmed/27713762 http://dx.doi.org/10.1186/s12986-016-0126-6 |
_version_ | 1782458287662301184 |
---|---|
author | Urry, Emily Jetter, Alexander Landolt, Hans-Peter |
author_facet | Urry, Emily Jetter, Alexander Landolt, Hans-Peter |
author_sort | Urry, Emily |
collection | PubMed |
description | BACKGROUND: Coffee consumption is a known inducer of cytochrome P450 1A2 (CYP1A2) enzyme activity. We recently observed that a group of type-2 diabetes patients consumed more caffeine (coffee) on a daily basis than non-type-2 diabetes controls. Here, we investigated whether type-2 diabetes cases may metabolize caffeine faster than non-type-2 diabetes controls. METHODS: To estimate CYP1A2 enzyme activity, an established marker of caffeine metabolism, we quantified the paraxanthine/caffeine concentration ratio in saliva in 57 type-2 diabetes and 146 non-type-2 diabetes participants in a case–control field study. All participants completed validated questionnaires regarding demographic status, health and habitual caffeine intake, and were genotyped for the functional -163C > A polymorphism of the CYP1A2 gene. RESULTS: In the diabetes group, we found a larger proportion of participants with the highly inducible CYP1A2 genotype. Furthermore, the paraxanthine/caffeine ratio, time-corrected to mitigate the impact of different saliva sampling times with respect to the last caffeine intake, was higher than in the control group. Participants who reported habitually consuming more caffeine than the population average showed higher CYP1A2 activity than participants with lower than average caffeine consumption. Multiple regression analyses revealed that higher caffeine intake was potentially an important mediator of higher CYP1A2 activity. CONCLUSIONS: Estimated CYP1A2 enzyme activity, and thus speed of caffeine metabolism, was higher in our type-2 diabetes group; this was possibly due to higher intake of caffeine, a known inducer of CYP1A2 enzyme activity. Given the fairly small sample sizes, the results need to be considered as preliminary and require validation in larger populations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12986-016-0126-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5052791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50527912016-10-06 Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake Urry, Emily Jetter, Alexander Landolt, Hans-Peter Nutr Metab (Lond) Research BACKGROUND: Coffee consumption is a known inducer of cytochrome P450 1A2 (CYP1A2) enzyme activity. We recently observed that a group of type-2 diabetes patients consumed more caffeine (coffee) on a daily basis than non-type-2 diabetes controls. Here, we investigated whether type-2 diabetes cases may metabolize caffeine faster than non-type-2 diabetes controls. METHODS: To estimate CYP1A2 enzyme activity, an established marker of caffeine metabolism, we quantified the paraxanthine/caffeine concentration ratio in saliva in 57 type-2 diabetes and 146 non-type-2 diabetes participants in a case–control field study. All participants completed validated questionnaires regarding demographic status, health and habitual caffeine intake, and were genotyped for the functional -163C > A polymorphism of the CYP1A2 gene. RESULTS: In the diabetes group, we found a larger proportion of participants with the highly inducible CYP1A2 genotype. Furthermore, the paraxanthine/caffeine ratio, time-corrected to mitigate the impact of different saliva sampling times with respect to the last caffeine intake, was higher than in the control group. Participants who reported habitually consuming more caffeine than the population average showed higher CYP1A2 activity than participants with lower than average caffeine consumption. Multiple regression analyses revealed that higher caffeine intake was potentially an important mediator of higher CYP1A2 activity. CONCLUSIONS: Estimated CYP1A2 enzyme activity, and thus speed of caffeine metabolism, was higher in our type-2 diabetes group; this was possibly due to higher intake of caffeine, a known inducer of CYP1A2 enzyme activity. Given the fairly small sample sizes, the results need to be considered as preliminary and require validation in larger populations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12986-016-0126-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-06 /pmc/articles/PMC5052791/ /pubmed/27713762 http://dx.doi.org/10.1186/s12986-016-0126-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Urry, Emily Jetter, Alexander Landolt, Hans-Peter Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake |
title | Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake |
title_full | Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake |
title_fullStr | Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake |
title_full_unstemmed | Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake |
title_short | Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake |
title_sort | assessment of cyp1a2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052791/ https://www.ncbi.nlm.nih.gov/pubmed/27713762 http://dx.doi.org/10.1186/s12986-016-0126-6 |
work_keys_str_mv | AT urryemily assessmentofcyp1a2enzymeactivityinrelationtotype2diabetesandhabitualcaffeineintake AT jetteralexander assessmentofcyp1a2enzymeactivityinrelationtotype2diabetesandhabitualcaffeineintake AT landolthanspeter assessmentofcyp1a2enzymeactivityinrelationtotype2diabetesandhabitualcaffeineintake |